AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1587378
Drug: Treatment-free control
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-free control group
Trial: 31803089
Drug: Bergen 4-day
RxNorm normalized name: LACTOBACILLUS BREVIS (ORLA-JENSEN, 1919) BERGEY ET AL., 1934
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bergen 4-day treatment (B4DT)
Trial: 29952241
Drug: Vibration stimulus
RxNorm normalized name: Limulus polyphemus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vibration stimulus (n = 14), low-frequency and low-magnitude (27-32 Hz, 0.3 g), 20 minutes, 3 times per week for 12 weeks
Trial: 27157469
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g soy protein isolate (SP20)
Trial: 27157469
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g soy protein isolate (SP40)
Trial: 27157469
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g soy protein isolate (SP0)
Trial: 10928300
Drug: Conventional agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional agents and calcium channel blockers
Trial: 6753245
Drug: Misonidazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misonidazole (400 mg/m2) administered with each of the 30 fractions of radiotherapy
Trial: 6753245
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered with each of the 30 fractions of radiotherapy
Trial: 28912639
Drug: Levobupivacaine only
RxNorm normalized name: Levobupivacaine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine only (0.5%) 0.4 mg·kg‐1
Trial: 28912639
Drug: Levobupivacaine (0.5%)
RxNorm normalized name: levobupivacaine 0.5 MG/ML
DrugBank: Levobupivacaine (DB01002)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (0.5%) 0.4 mg·kg‐1 + adrenaline (1:200,000)
Trial: 21610205
Drug: Gastric-retentive extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric-retentive extended-release (ER) formulation (4 hours)
Trial: 21610205
Drug: Gastric-retentive extended-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastric-retentive extended-release (ER) formulation (6 hours)
Trial: 21610205
Drug: M-ER (comparator
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M-ER (comparator ER tablet)
Trial: 17457961
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg GBE complexed with phosphatidylserine
Trial: 17457961
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg GBE complexed with phosphatidylcholine
Trial: 17457961
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg GBE
Trial: 16449074
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy plus one Botulinum Toxin A injection
Trial: 14501381
Drug: Selenized yeast
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenized yeast (both doses)
Trial: 10323688
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of sulbactam‐ampicillin combination
Trial: 1930858
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 to 40 mg/day for 8 weeks)
Trial: 1930858
Drug: Captopril (37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (37.5 to 75 mg/day for 8 weeks)
Trial: 7172738
Drug: Lotion V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lotion V
Trial: 7172738
Drug: Lotion K
RxNorm normalized name: SA 6% Lotion Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lotion K
Trial: 21635709
Drug: Tamoxifen (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (5 years monotherapy)
Trial: 21635709
Drug: Letrozole (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (5 years monotherapy)
Trial: 11392406
Drug: Levodopa-carbidopa suspension
RxNorm normalized name: carbidopa / levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa-carbidopa suspension in Ora Plus/Ora Sweet
Trial: 11392406
Drug: Levodopa-carbidopa suspension
RxNorm normalized name: carbidopa / levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa-carbidopa suspension with ascorbic acid
Trial: 11392406
Drug: Levodopa-carbidopa suspension
RxNorm normalized name: carbidopa / levodopa
DrugBank: Levodopa (DB01235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levodopa-carbidopa suspension
Trial: 1846438
Drug: Continuous schedule
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous schedule (daily estrogen and progestin)
Trial: 1846438
Drug: Sequential schedule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential schedule (conjugated estrogen on days 1‐25, medroxyprogesterone acetate on days 16‐25)
Trial: 6356630
Drug: tiaprofenic acid
RxNorm normalized name: tiaprofenic acid
DrugBank: Tiaprofenic acid (DB01600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tiaprofenic acid (daily dose 600 mg)
Trial: 6356630
Drug: ibuprofen (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ibuprofen (daily dose 1200 mg)
Trial: 22708417
Drug: Standard pharmacotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard pharmacotherapy
Trial: 25719617
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (imipramine 75 mg/d + pregabalin 300 mg/d)
Trial: 25719617
Drug: Imipramine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (75 mg/d)
Trial: 25719617
Drug: Pregabalin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (300 mg/d)
Trial: 24733680
Drug: Weekly problem-solving
RxNorm normalized name: Solv X
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly problem-solving group intervention
Trial: 22282884
Drug: Cerebrolysin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin (30 mL daily for 10 days)
Trial: 22282884
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline solution, intravenous infusion for 10 days)
Trial: 15626943
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (HBV) plus measles vaccine
Trial: 15626943
Drug: Measles vaccine
RxNorm normalized name: Measles vaccine
DrugBank: Measles virus vaccine live attenuated (DB10315)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measles vaccine only
Trial: 15626943
Drug: Hepatitis B
RxNorm normalized name: HEPATITIS B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepatitis B vaccine (HBV)
Trial: 27265388
Drug: Dark chocolate
RxNorm normalized name: Ensure Original Dark Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dark chocolate (>85% cocoa), 40 g/day for 2 weeks
Trial: 27265388
Drug: Milk chocolate
RxNorm normalized name: Meritene Milk Chocolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk chocolate (<35% cocoa), 40 g/day for 2 weeks
Trial: 24518826
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg·kg⁻¹ body mass)
Trial: 20300126
Drug: Usual treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual treatment group (21 patients)
Trial: 18836927
Drug: Psychotherapeutic day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapeutic day treatment programme (5 months duration, including psychodynamic and cognitive-based therapy in group/individual settings)
Trial: 16651155
Drug: Local anesthesia
RxNorm normalized name: Esters of benzoic acid for local anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthesia with propofol infusion (LAP)
Trial: 9335416
Drug: Losartan (combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (combined with ACE inhibitor)
Trial: 3021083
Drug: Clonidine hydrochloride
RxNorm normalized name: Clonidine Hydrochloride
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine hydrochloride (alpha 2‐adrenergic receptor agonist)
Trial: 3021083
Drug: Yohimbine (alpha
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (alpha 2‐adrenergic receptor antagonist)
Trial: 30665850
Drug: Continuous bilateral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous bilateral ESPB (0.25 mL/kg/side of ropivacaine 0.5%)
Trial: 30665850
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (IV morphine, 0.5 mg/h and IV nefopam, 100 mg/24 h)
Trial: 27699819
Drug: PSA growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSA growth curve model with a threshold of 0.37 ng/ml/year
Trial: 27699819
Drug: PSA growth
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSA growth curve model with a threshold of 0.99 ng/ml/year in African-American men (AA)
Trial: 19172243
Drug: Trientine (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trientine (600 mg orally twice daily)
Trial: 7755459
Drug: ACE inhibitor
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor (quinapril 20 mg)
Trial: 797547
Drug: Halcinonide cream
RxNorm normalized name: Halcinonide Cream
DrugBank: Halcinonide (DB06786)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halcinonide cream
Trial: 1094960
Drug: Betamethasone valerate
RxNorm normalized name: Betamethasone Valerate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone valerate cream
Trial: 26500862
Drug: Narrowband UVB
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Narrowband UVB (NBUVB) phototherapy at a fixed dose of 250 mJ/cm² three times a week for 4 weeks
Trial: 16669305
Drug: Weekly ultrasound
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly ultrasound combined with standard care
Trial: 15606390
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (5‐aminlevulinic acid 30 mg/kg and red light)
Trial: 15606390
Drug: Argon plasma
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon plasma coagulation (administered at a power setting of 65 W)
Trial: 8742796
Drug: DMT (naturally
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DMT (naturally occurring short‐acting hallucinogen), dosage and duration not specified
Trial: 31992604
Drug: Telehealthcare solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telehealthcare solution (Telekit with tablet, digital blood pressure monitor, and scale)
Trial: 31992604
Drug: Telehealthcare solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telehealthcare solution
Trial: 25729661
Drug: BoNT‐A (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BoNT‐A (40 Ipsen units per injection)
Trial: 18155484
Drug: Buccal infiltrations
RxNorm normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal infiltrations (BI) with 1.7 mL of 4% articaine with 1:100,000 adrenaline
Trial: 11353990
Drug: Pentoxifylline (PTX)
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline (PTX) 800 mg/day with interferon
Trial: 7761010
Drug: Buprenorphine (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.01 mg/kg) with a primer of 0.003 mg/kg of buprenorphine
Trial: 7761010
Drug: Buprenorphine (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.01 mg/kg) with a primer of 0.5 mg/kg of ketorolac
Trial: 3186087
Drug: Intrapartum treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapartum treatment with ampicillin and gentamicin during labor
Trial: 3186087
Drug: Postpartum treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postpartum treatment
Trial: 31448420
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen low dose
Trial: 31448420
Drug: Intravenous acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acetaminophen high dose
Trial: 29969928
Drug: Tiotropium as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium as add-on therapy to inhaled corticosteroids
Trial: 29969928
Drug: Long acting
RxNorm normalized name: Long Acting Nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long acting beta agonist as add-on therapy to inhaled corticosteroids
Trial: 25275069
Drug: Daily erlotinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily erlotinib for 12 consecutive days prior to docetaxel (Arm A)
Trial: 25275069
Drug: Docetaxel followed
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel followed by daily erlotinib (Arm B)
Trial: 17488457
Drug: Blood glucose
RxNorm normalized name: Blood Glucose Book
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood glucose clamped at 5 mmol/l
Trial: 17488457
Drug: Blood glucose
RxNorm normalized name: Blood Glucose Book
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood glucose clamped at 15 mmol/l
Trial: 15337134
Drug: Levetiracetam (LEV)
RxNorm normalized name: Levetiracetam
DrugBank: Levetiracetam (DB01202)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Levetiracetam (LEV) 500 mg b.d., titrated to a maximum of 3 g/day
Trial: 8903618
Drug: ACE inhibitors
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors monotherapy
Trial: 11527126
Drug: Bisoprolol 10
RxNorm normalized name: bisoprolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 10 mg o.d.
Trial: 3319646
Drug: Chlorthalidone 50
RxNorm normalized name: chlorthalidone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone 50 mg o.d.
Trial: 28067701
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia (control)
Trial: 23407853
Drug: Sitagliptin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin monotherapy (100 mg)
Trial: 23407853
Drug: Atorvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (40 mg for 5 days) + Sitagliptin (100 mg on day 5)
Trial: 15565033
Drug: 5-mL vacuum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-mL vacuum collection tubes
Trial: 15565033
Drug: 10-mL vacuum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-mL vacuum collection tubes
Trial: 11487548
Drug: Irbesartan 150
RxNorm normalized name: irbesartan 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 150 mg/d for 1 week
Trial: 7625469
Drug: Fluoxetine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (up to 80 mg/day)
Trial: 26645407
Drug: Subcutaneous (SC)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (SC) trastuzumab 600 mg
Trial: 26645407
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) trastuzumab (weight-based)
Trial: 19134350
Drug: Group G
RxNorm normalized name: Prostaglandin group G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group G (puberty gingivitis)
Trial: 12876091
Drug: Acarbose 100
RxNorm normalized name: acarbose 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acarbose 100 mg three times a day
Trial: 9097988
Drug: Mesalamine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalamine (750 mg four times a day for 48 weeks)
Trial: 17907289
Drug: Intra-arterial chemotherapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin, 5-FU, and enteric-coated tegafur/uracil
Trial: 10212791
Drug: Intra-arterial chemotherapy
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial chemotherapy
Trial: 15167313
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (while continuing 2.5 mg of oral medroxyprogesterone acetate)
Trial: 15167313
Drug: Oral estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estrogen (0.625 mg of conjugated equine estrogen plus 2.5 mg of medroxyprogesterone acetate)
Trial: 11181465
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg/d for 3 months
Trial: 3326743
Drug: 3 Lf
RxNorm normalized name: HYDROXYPROPYL CELLULOSE LF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 Lf diphtheria vaccine
Trial: 3326743
Drug: 7.5 Lf
RxNorm normalized name: Diphtheria Toxoid, Adsorbed/Pertussis Vaccine, Acellular/Tetanus Toxoid 7.5 LF U/0.5 ML-300 HA U/0.5 ML-5 LF U/0.5 ML Intramuscular Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 Lf diphtheria vaccine
Trial: 29268022
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection into the rotator interval (RI)
Trial: 29268022
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection into the intra-articular (IA) space
Trial: 29268022
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection into the subacromial (SA) space
Trial: 28577840
Drug: WATCHMAN implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WATCHMAN implant
Trial: 11145281
Drug: PPI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI treatment
Trial: 17373915
Drug: Rifaximin (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin (1200 mg/day)
Trial: 3669757
Drug: Lymphoblastoid alpha-interferon
RxNorm normalized name: interferon alfa-n1 lymphoblastoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lymphoblastoid alpha-interferon (3 mega units daily subcutaneously until complete or partial response)
Trial: 29565302
Drug: Daily group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily group hygiene activities
Trial: 27837658
Drug: OLZ +
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OLZ + ZIP (combination therapy)
Trial: 27837658
Drug: ZIP (ziprasidone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZIP (ziprasidone monotherapy)
Trial: 25424689
Drug: Perindopril 2
RxNorm normalized name: perindopril 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 2 mg plus lercanidipine 5 mg (Group A)
Trial: 25424689
Drug: Lercanidipine 10
RxNorm normalized name: lercanidipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lercanidipine 10 mg (Group B)
Trial: 25424689
Drug: Perindopril 4
RxNorm normalized name: perindopril 4 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 4 mg (Group C)
Trial: 23932463
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg/d
Trial: 11348939
Drug: SR bupropion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR bupropion treatment (100, 150, or 300 mg/d) for 7 weeks
Trial: 8989016
Drug: Glycopyrrolate 8
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate 8 micrograms/kg and neostigmine 50 micrograms/kg (Group G)
Trial: 8484510
Drug: Propofol (approximately
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (approximately 3 micrograms/mL) with 60% nitrous oxide
Trial: 8484510
Drug: Esmolol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol infusion (100 micrograms.kg-1 x min-1) during propofol anesthesia
Trial: 3117150
Drug: Nebulizer administration
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulizer administration of 4 mg terbutaline
Trial: 3117150
Drug: Nebuhaler administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebuhaler administration of 4 mg terbutaline
Trial: 28449618
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual face‐to‐face physical therapy)
Trial: 20502134
Drug: Sublingual tizanidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual tizanidine HCl (8 mg)
Trial: 20502134
Drug: Oral tizanidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tizanidine HCl (8 mg)
Trial: 11754710
Drug: Rofecoxib, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib, 25 mg/d